T&L Co., Ltd. (KOSDAQ:340570)

Market Cap	411.67B
Revenue (ttm)	185.32B
Net Income (ttm)	45.67B
Shares Out	8.07M
EPS (ttm)	5,658.37
PE Ratio	9.01
Forward PE	8.02
Dividend	750.00 (1.47%)
Ex-Dividend Date	Dec 27, 2024

Volume	26,242
Average Volume	32,765
Open	51,200
Previous Close	51,300
Day's Range	50,400 - 51,300
52-Week Range	50,500 - 85,600
Beta	0.15
RSI	35.31
Earnings Date	Nov 14, 2025

About T&L Co., Ltd.

T&L Co., Ltd. engages in the manufacture and sale of medical and polymer material products in South Korea. Its chemical products include water borne resins, hardeners, functional additives, and urethane foam; wound care products, including hydrocolloid, foam, hydrogel, silicone, alginate, and other products; and orthopedic products, such as cast, splint, and other products. T&L Co., Ltd. was founded in 1998 and is headquartered in Yongin-si, South Korea.

• Industry: Orthopedic, Prosthetic, and Surgical Appliances and Supplies
• Founded: 1998
• Employees: 242
• Stock Exchange: KOSDAQ
• Ticker Symbol: 340570

Financial Performance

In 2024, T&L Co., Ltd.'s revenue was 174.89 billion, an increase of 51.47% compared to the previous year's 115.46 billion. Earnings were 46.41 billion, an increase of 69.13%.